Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Rheumatology | Monthly Briefing

Back to Journal Articles

September 2012 Briefing - Rheumatology

Last Updated: October 01, 2012.

 

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for September 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Pain Intensity in Juvenile Arthritis Varies Widely

FRIDAY, Sept. 28 (HealthDay News) -- In youth with juvenile idiopathic arthritis (JIA), pain intensity varies within days, impacting patient quality of life, according to a study published online Sept. 12 in Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Topical NSAIDs Effective for Chronic Musculoskeletal Pain

THURSDAY, Sept. 27 (HealthDay News) -- Topical nonsteroidal anti-inflammatory drugs (NSAIDs) can provide effective pain relief for chronic musculoskeletal pain in adults, according to a review published online Sept. 12 in The Cochrane Library.

Abstract
Full Text (subscription or payment may be required)

Myogenes Identified for Spondyloarthritis Synovitis

THURSDAY, Sept. 27 (HealthDay News) -- There are disease-specific and inflammation-independent stromal alterations in spondyloarthritis (SpA) synovitis, according to a study published online Sept. 12 in Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Medicare Knee Replacement Numbers Up Over Last 20 Years

TUESDAY, Sept. 25 (HealthDay News) -- From 1991 to 2010 there was a 161.5 percent annual volume increase in primary total knee arthroplasty (TKA) among Medicare enrollees as well as an increase in per capita utilization, according to research published in the Sept. 26 issue of the Journal of the American Medical Association.

Abstract
Full Text

Gout Is Primary Indication in About 0.2 Percent of ER Visits

TUESDAY, Sept. 18 (HealthDay News) -- Gout is the primary indication in about 0.2 percent of emergency department visits annually, according to a study published online Sept. 4 in Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Study Looks at Pain Processing Abnormalities in Knee OA

MONDAY, Sept. 17 (HealthDay News) -- For patients with knee osteoarthritis (K-OA), the lack of correlation between clinical pain and radiographic evidence of disease severity may be due to central sensitization, according to a study published online Sept. 7 in Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Not All Docs/Nurses Want to Be Asked About Hand Hygiene

FRIDAY, Sept. 7 (HealthDay News) -- Although most health care workers (HCWs) appreciate the role of patients in preventing health care-associated infection, a considerable proportion are uncomfortable with patients asking about their hand hygiene, according to a letter published online Sept. 3 in the Archives of Internal Medicine.

Full Text (subscription or payment may be required)

Elevated Rheumatoid Factor Ups Risk of Developing RA

FRIDAY, Sept. 7 (HealthDay News) -- Individuals in the general population with elevated levels of rheumatoid factor have a significantly increased risk of developing rheumatoid arthritis, according to a study published online Sept. 6 in BMJ.

Full Text
Editorial (subscription or payment may be required)

Score Can Assess One-Year Risk of Serious Infection in RA

THURSDAY, Sept. 6 (HealthDay News) -- A risk score based on rheumatoid arthritis (RA) disease characteristics and comorbidities has been developed and validated for assessing the one-year risk of serious infection, according to research published in the September issue of Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

No Increased Risk of Cancer With Biologics in Rheumatoid Arthritis

TUESDAY, Sept. 4 (HealthDay News) -- For patients with rheumatoid arthritis (RA), the use of biologic response modifiers (BRMs) for at least six months is not associated with an increased risk of malignancy compared with placebo or other disease-modifying antirheumatic drugs (DMARDs), according to a study published in the Sept. 5 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)

In RA, Hand Surgery Improves Function, Appearance

MONDAY, Sept. 3 (HealthDay News) -- Treating rheumatoid arthritis (RA) patients with severe hand deformities with a silicone metacarpophalangeal joint arthroplasty (SMPA) procedure produces significant, long-term improvement in hand function and appearance, according to research published in the September issue of Arthritis Care & Research.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 ScoutNews, LLC. All rights reserved.


Previous: September 2012 Briefing - Pulmonology Next: September 2012 Briefing - Surgery

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.